Unique Wealth Strategies LLC Acquires Shares of 10,848 CVS Health Co. (NYSE:CVS)

Unique Wealth Strategies LLC bought a new position in CVS Health Co. (NYSE:CVS) during the fourth quarter, HoldingsChannel reports. The firm bought 10,848 shares of the pharmacy operator’s stock, valued at approximately $857,000.

Several other hedge funds have also bought and sold shares of the business. Atticus Wealth Management LLC increased its position in shares of CVS Health by 149.0% during the fourth quarter. Atticus Wealth Management LLC now owns 366 shares of the pharmacy operator’s stock worth $29,000 after acquiring an additional 219 shares in the last quarter. Cornerstone Planning Group LLC raised its stake in shares of CVS Health by 111.5% in the third quarter. Cornerstone Planning Group LLC now owns 461 shares of the pharmacy operator’s stock worth $32,000 after purchasing an additional 243 shares during the last quarter. ZRC Wealth Management LLC boosted its position in shares of CVS Health by 400.0% during the fourth quarter. ZRC Wealth Management LLC now owns 500 shares of the pharmacy operator’s stock valued at $39,000 after buying an additional 400 shares during the last quarter. Coston McIsaac & Partners grew its holdings in CVS Health by 42.6% during the fourth quarter. Coston McIsaac & Partners now owns 539 shares of the pharmacy operator’s stock worth $42,000 after buying an additional 161 shares in the last quarter. Finally, Tennessee Valley Asset Management Partners purchased a new stake in CVS Health in the 4th quarter valued at $50,000. Institutional investors and hedge funds own 80.66% of the company’s stock.

Analysts Set New Price Targets

Several analysts have recently issued reports on CVS shares. Cantor Fitzgerald reiterated an “overweight” rating and issued a $87.00 target price on shares of CVS Health in a research note on Wednesday, April 10th. SVB Leerink initiated coverage on shares of CVS Health in a research report on Monday, February 26th. They set an “outperform” rating and a $88.00 target price on the stock. Wells Fargo & Company decreased their price target on CVS Health from $83.00 to $76.00 and set an “equal weight” rating for the company in a research report on Monday, April 8th. StockNews.com downgraded CVS Health from a “buy” rating to a “hold” rating in a research note on Thursday, February 15th. Finally, Leerink Partnrs reiterated an “outperform” rating on shares of CVS Health in a research note on Monday, February 26th. Four analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $89.44.

Insiders Place Their Bets

In other news, EVP Prem S. Shah sold 29,473 shares of the company’s stock in a transaction on Friday, February 16th. The shares were sold at an average price of $76.95, for a total value of $2,267,947.35. Following the completion of the sale, the executive vice president now owns 39,765 shares of the company’s stock, valued at approximately $3,059,916.75. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 0.24% of the company’s stock.

CVS Health Stock Performance

Shares of NYSE:CVS traded down $0.15 during midday trading on Friday, reaching $67.18. 6,396,438 shares of the company traded hands, compared to its average volume of 8,376,818. CVS Health Co. has a 12 month low of $64.41 and a 12 month high of $83.25. The firm’s fifty day moving average price is $74.42 and its two-hundred day moving average price is $73.64. The company has a quick ratio of 0.63, a current ratio of 0.86 and a debt-to-equity ratio of 0.77. The firm has a market capitalization of $84.68 billion, a price-to-earnings ratio of 10.40, a price-to-earnings-growth ratio of 0.89 and a beta of 0.52.

CVS Health (NYSE:CVS) last announced its quarterly earnings results on Wednesday, February 7th. The pharmacy operator reported $2.12 earnings per share for the quarter, beating the consensus estimate of $2.01 by $0.11. CVS Health had a return on equity of 15.25% and a net margin of 2.33%. The firm had revenue of $93.81 billion for the quarter, compared to analysts’ expectations of $90.58 billion. During the same period in the prior year, the business posted $1.99 earnings per share. The company’s revenue was up 11.9% on a year-over-year basis. On average, equities analysts expect that CVS Health Co. will post 8.31 earnings per share for the current year.

CVS Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, May 1st. Shareholders of record on Monday, April 22nd will be paid a $0.665 dividend. This represents a $2.66 annualized dividend and a yield of 3.96%. The ex-dividend date of this dividend is Friday, April 19th. CVS Health’s dividend payout ratio is currently 41.18%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.